Clinical Trials Browser

NIH × Multiple Myeloma × Bevacizumab × Clear all

NCT00410605 2017-09-01

Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma

Phase 2 Completed

39 enrolled 10 charts

Multiple Myeloma

NCT00022607 2013-06-24

Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell